Related Experiment Video
Updated: Dec 14, 2025

08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
16.8K
Addressing Cellular Heterogeneity in Cancer through Precision Proteomics.
Journal of Proteome Research
|July 23, 2020
Summary
Investigating cellular heterogeneity using protein analysis advances cancer research. Precision proteomics offers tailored approaches for understanding cell differences and improving therapeutic efficacy.
Area of Science:
- Proteomics
- Cellular Biology
- Cancer Research
Background:
- Cellular functions are dictated by molecular phenotypes, leading to heterogeneity within and between cell types.
- Understanding this heterogeneity is crucial for diagnosing and manipulating biological systems.
- Tumor heterogeneity presents a significant challenge for developing effective cancer therapeutics.
Purpose of the Study:
- To review experimental approaches for investigating cellular heterogeneity at the protein level.
- To highlight advancements in bottom-up single-cell proteomic analysis.
- To discuss the opportunities and challenges of these methods in cancer research.
Main Methods:
- Review of protein-level experimental techniques for studying cellular heterogeneity.
- Focus on innovative approaches and technical developments in single-cell proteomics.
- Discussion of the advantages and limitations of various experimental methodologies.
Main Results:
- Innovative techniques have enabled bottom-up single-cell proteomic analysis.
- Various experimental approaches offer distinct advantages for different biological questions.
- The concept of "precision proteomics" is introduced for tailored investigations.
Conclusions:
- Protein-level analysis is key to understanding cellular heterogeneity.
- Single-cell proteomics provides powerful tools for cancer research.
- "Precision proteomics" enables customized strategies for studying biological systems.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
14.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.3K
Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K

